Access, SpePharm in European MuGard pact
This article was originally published in Clinica
Executive Summary
Dallas, Texas-based Access Pharmaceuticals has signed an agreement which will see its oral wound rinse product MuGard marketed in Europe by Dutch company SpePharm. The agreement incorporates the European Union plus Switzerland, Norway and Iceland, and will see SpePharm become responsible for manufacturing and regulatory approval of the product within this territory.